Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.

<!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid&g...

Full description

Saved in:

Bibliographic Details
Main Authors:	Omar Julián Hernández Ojeda, Marcos Félix Osorio Pagola, Orelvis Martínez Martínez, Denis Monzón Vega, Mabel Vega Galindo
Format:	Article
Language:	Spanish
Published:	Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2011-07-01
Series:	Medisur
Subjects:	hepatitis viral humana hepatitis c, virus hepatitis c interferón alfa-2b. ribavirina
Online Access:	http://medisur.sld.cu/index.php/medisur/article/view/1484
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Caracterización de pacientes con Hepatitis C en el servicio de hemodiálisis. Cienfuegos 2019
by: Lizette Rodríguez Fernández, et al.
Published: (2021-04-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

Factors associated with seropositivity of Hepatitis B & C: A case control study at Azad Jammu and Kashmir
by: Muhammad Abdul Quddus, et al.
Published: (2023-04-01)

Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
by: M. V. Mayevskaya
Published: (2011-06-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Seroprevalence of hepatitis B and C virus among a group of hemophilia patients in Kurdistan Region, Iraq
by: Salih A. Hama
Published: (2025-02-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Global progress, challenges and strategies in eliminating public threat of viral hepatitis
by: Sihui Zhang, et al.
Published: (2025-02-01)

Epidemiological Study of Hepatitis B, C and HIV Cases among the Foreigners Visiting Sulaimani City from 2013 Through 2016
by: Mohammed Omer Mohammed, et al.
Published: (2019-10-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection
by: Andrea Magri, et al.
Published: (2024-12-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
by: Elmas Pinar Kahraman Kilbas, et al.
Published: (2025-01-01)

Evaluation of liver fibrosis in HCV-infected patients using two-dimensional shear-wave elastography (2D-SWE) before and after antiviral treatment
by: Inglot Marcin, et al.
Published: (2024-12-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis
by: Sarah R. Donaldson, et al.
Published: (2025-01-01)

Diagnosis and management of rheumatic manifestations of Hepatitis B, Hepatitis C and immunodeficiency Virus
by: Arun Ramesh Chogle
Published: (2017-01-01)

Acute hepatitis of non-specified etiology
by: Ye. V. Tsyganova, et al.
Published: (2011-02-01)

Cognitive Impairments in Viral Hepatitis Patients: Causes, Manifestations, and Impact on Quality of Life
by: Tatyana Vasiliyevna Polukchi
Published: (2025-01-01)

The prognostic value of ferritinemia level in patients with chronic hepatitis C
by: N. C. Sargsyants, et al.
Published: (2013-07-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
by: Jiayi Wang, et al.
Published: (2024-12-01)

Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
by: S. N. Batskikh
Published: (2012-11-01)

Hyperferritinemia at the patient with chronic hepatitis C
by: Ye. N. German, et al.
Published: (2009-02-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

PATHOPHYSIOLOGIC MECHANISMS OF THE INFLUENCE OF TISSUE RESPIRATION ENZYMES ON THE MITOCHONDRIAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS C
by: I.Y. Bagmut, et al.
Published: (2018-03-01)

Infection with hepatitis C virus as a cause of cirrhosis – case study
by: Lidia Sierpińska, et al.
Published: (2025-01-01)

Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy
by: Jennifer Leigh, et al.
Published: (2024-12-01)

Role of alpha-fetoprotein in complex diagnostics of progressing course of chronic hepatitis B and C
by: I. A. Belavina, et al.
Published: (2012-06-01)